Home » USA: FDA authorizes awaited drug for Alzheimer’s – Last Hour

USA: FDA authorizes awaited drug for Alzheimer’s – Last Hour

by admin
USA: FDA authorizes awaited drug for Alzheimer’s – Last Hour

(ANSA) – NEW YORK, 06 JAN – The US Food and Drug Administration authorizes the long-awaited drug for Alzheimer’s by Eisai and Biogen. In the studies performed, Leqembi has shown promising results for the treatment of the disease, which affects about 6.5 million Americans, with an evident slowdown of the disease. The FDA has given the drug an accelerated green light, which means that the two companies will have to conduct more studies. (HANDLE).

breaking latest news © Copyright ANSA


This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy